Changing Paradigms in the Topical Treatment of Psoriasis
The Dermatology Digest
APRIL 29, 2024
Mona Shahriari, MD, Assistant Clinical Professor of Dermatology at Yale University School of Medicine in New Haven, CT, and Associate Director of Clinical Trials at CCD Research, discusses how next-generation non-steroidal topical therapies for psoriasis including tapinarof (Vtama, Dermavant) cream, a novel, aryl hydrocarbon receptor agonist, are raising the bar, helping patients regain control of their psoriasis and their lives.
Let's personalize your content